Showing results (1251-1260 of 2,738) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|December 6, 2016
ABCB1 genotyping in the treatment of depressionTanja Maria Brückl, Manfred Uhr
Pharmacogenomics|December 16, 2016
Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasisRocío Prieto-Pérez, Mar Llamas-Velasco, Teresa Cabaleiro, et al.
Pharmacogenomics|December 16, 2016
Fatty acid amide hydrolase-morphine interaction influences ventilatory response to hypercapnia and postoperative opioid outcomes in childrenVidya Chidambaran, Valentina Pilipenko, Kristie Spruance, et al.
Pharmacogenomics|February 26, 2019
The interleukin-17 G-197A polymorphism is associated with cyclosporine metabolism and transplant rejection in liver transplant recipientsBo Sun, Junwei Gao, Weifeng Shi, et al.
Pharmacogenomics|March 28, 2017
Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patientsSarah Allegra, Silvia De Francia, Jessica Cusato, et al.
Pharmacogenomics|March 28, 2017
Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorderBradley Watmuff, Bangyan Liu, Rakesh Karmacharya
Pharmacogenomics|February 16, 2019
Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosisAnushka Naidoo, Maxwell Chirehwa, Veron Ramsuran, et al.
Pharmacogenomics|February 16, 2019
Population pharmacokinetic and pharmacogenetics of imatinib in Chinese patients with chronic myeloid leukemiaQing Wang, Zhi-Ping Jiang, Er-Qian Yu, et al.
Pharmacogenomics|March 1, 2017
CYP2D6 pharmacogenetic and oxycodone pharmacokinetic association study in pediatric surgical patientsRajiv Balyan, Marc Mecoli, Raja Venkatasubramanian, et al.
Pharmacogenomics|March 1, 2017
Systematic screening for CYP3A4 genetic polymorphisms in a Han Chinese populationGuo-Xin Hu, Da-Peng Dai, Hao Wang, et al.
Pageof 274